Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

HIV-1 latency reversal agent boosting is not limited by opioid use

Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche, Alex Olson, Kendyll Coxen, Heather Corry, Hannah Jordan, Kiera Clayton, Nina Lin, View ORCID ProfileAthe Tsibris
doi: https://doi.org/10.1101/2023.05.26.23290576
Tyler Lilie
1Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Bouzy
1Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Archana Asundi
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Taylor
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
3Grayken Center for Addiction, Boston Medical Center, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Roche
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Olson
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kendyll Coxen
1Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Corry
1Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Jordan
1Brigham and Women’s Hospital, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiera Clayton
4Department of Pathology, University of Massachusetts T.H. Chan School of Medicine, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nina Lin
2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Athe Tsibris
1Brigham and Women’s Hospital, Boston, MA, USA
5Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Athe Tsibris
  • For correspondence: atsibris{at}bwh.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2023.05.26.23290576
History 
  • June 4, 2024.

Article Versions

  • Version 1 (June 3, 2023 - 21:01).
  • You are viewing Version 2, the most recent version of this article.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Tyler Lilie1,†,
  2. Jennifer Bouzy1,†,
  3. Archana Asundi2,
  4. Jessica Taylor2,3,
  5. Samantha Roche2,
  6. Alex Olson2,
  7. Kendyll Coxen1,
  8. Heather Corry1,
  9. Hannah Jordan1,
  10. Kiera Clayton4,
  11. Nina Lin2,‡ and
  12. Athe Tsibris1,5,‡,*
  1. 1Brigham and Women’s Hospital, Boston, MA, USA
  2. 2Department of Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA USA
  3. 3Grayken Center for Addiction, Boston Medical Center, Boston, MA USA
  4. 4Department of Pathology, University of Massachusetts T.H. Chan School of Medicine, Worcester, MA, USA
  5. 5Harvard Medical School, Boston, MA, USA
  1. ↵*Correspondence: atsibris{at}bwh.harvard.edu
  1. ↵† These authors contributed equally to this work

  2. ↵‡ These authors contributed equally to this work

Back to top
PreviousNext
Posted June 04, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
HIV-1 latency reversal agent boosting is not limited by opioid use
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche, Alex Olson, Kendyll Coxen, Heather Corry, Hannah Jordan, Kiera Clayton, Nina Lin, Athe Tsibris
medRxiv 2023.05.26.23290576; doi: https://doi.org/10.1101/2023.05.26.23290576
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler Lilie, Jennifer Bouzy, Archana Asundi, Jessica Taylor, Samantha Roche, Alex Olson, Kendyll Coxen, Heather Corry, Hannah Jordan, Kiera Clayton, Nina Lin, Athe Tsibris
medRxiv 2023.05.26.23290576; doi: https://doi.org/10.1101/2023.05.26.23290576

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • HIV/AIDS
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)